Literature DB >> 8253831

The erythropoietin receptor: its role in hematopoiesis and myeloproliferative diseases.

G D Longmore1, S S Watowich, D J Hilton, H F Lodish.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8253831      PMCID： PMC2290895          DOI： 10.1083/jcb.123.6.1305

Source DB:  PubMed          Journal:  J Cell Biol        ISSN： 0021-9525            Impact factor:   10.539


× No keyword cloud information.
  38 in total

1.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

2.  Tyrosine kinase activation through the extracellular domains of cytokine receptors.

Authors:  T Chiba; Y Nagata; M Machide; A Kishi; H Amanuma; M Sugiyama; K Todokoro
Journal:  Nature       Date:  1993-04-15       Impact factor: 49.962

3.  Subunit structure of the erythropoietin receptor analyzed by 125I-Epo cross-linking in cells expressing wild-type or mutant receptors.

Authors:  O Miura; J N Ihle
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

4.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.

Authors:  B A Witthuhn; F W Quelle; O Silvennoinen; T Yi; B Tang; O Miura; J N Ihle
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

5.  Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors.

Authors:  O Miura; J L Cleveland; J N Ihle
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: evidence for differentiation stage-specific regulation.

Authors:  C Heberlein; K D Fischer; M Stoffel; J Nowock; A Ford; U Tessmer; C Stocking
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

7.  Homodimerization and constitutive activation of the erythropoietin receptor.

Authors:  S S Watowich; A Yoshimura; G D Longmore; D J Hilton; Y Yoshimura; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130.

Authors:  A Yoshimura; H F Lodish
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

9.  Disulfide bonding controls the processing of retroviral envelope glycoproteins.

Authors:  B C Gliniak; S L Kozak; R T Jones; D Kabat
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

10.  Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.

Authors:  A de la Chapelle; A L Träskelin; E Juvonen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205
View more
  4 in total

1.  Cloning expeditions: risky but rewarding.

Authors:  Harvey Lodish
Journal:  Mol Cell Biol       Date:  2013-09-23       Impact factor: 4.272

2.  Erythropoietin in thyroid cancer.

Authors:  C M Yates; A Patel; K Oakley; A Helms; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

Review 3.  The erythropoietin receptor: molecular structure and hematopoietic signaling pathways.

Authors:  Stephanie S Watowich
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

4.  The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection.

Authors:  Ming-Chang Hu; Mingjun Shi; Han J Cho; Jianning Zhang; Alevtina Pavlenco; Shuzhen Liu; Sachdev Sidhu; Lily J-S Huang; Orson W Moe
Journal:  Kidney Int       Date:  2013-05-01       Impact factor: 10.612
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.